As a society we rarely discuss death. Heck, we can\’t even say the words – that someone has died or is dead – instead using euphemisms like \”passed on\” or \”gone.\” Imagine how much harder it is to know that you are dying and doing so quite soon.
The psychedelic healing renaissance is all around us, seeping into the mainstream culture more and more. Decriminalization and clinical trials abound especially in order to treat the treatment-resistant part of the population suffering from various maladies and with promising results. Author Michael Pollen dove in to find out and show us more…
Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.
Festivals can be an amazing, life changing experience and to keep it on the positive side, we thought we’d review the fav 15 festival survival tips to make sure that not only will you survive any festival but you’ll thrive from it!
(more…)
Matthew Johnson, an associate professor of psychiatry at Johns Hopkins and the lead author of the study, was interested in psilocybin because of the success researchers had in using LSD to treat alcoholics in the 1960s. He liked that psilocybin was shorter-acting than LSD and had less societal stigma. It also has few side effects or addictive properties of its own. Studies have already shown that hallucinogens might relieve everything from clinical depression to anxiety among cancer patients. Smoking, meanwhile, is relatively easy to study—not as deadly as, say, heroin and readily detectable with a urine test.
(more…)
This is the case to legalize psychedelics. Although the drugs have gotten some media attention in recent years for helping cancer patients deal with their fear of death and helping people quit smoking, there\’s also a similar potential boon for the non-medical, even recreational hallucinogenic user. As hallucinogens get a renewed look by researchers, they\’re finding that the substances may improve almost anyone\’s mood and quality of life — as long as they\’re taken in the right setting, typically a controlled environment.
(more…)
Robin Carhart-Harris has been conducting pioneering brain imaging studies of psychedelics for depression. Most recently, he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression, and his talk looks at how these drugs can be used in treatment.
(more…)